X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurology (319) 319
medical and health sciences (294) 294
medicin och hälsovetenskap (294) 294
alzheimer's disease (248) 248
clinical medicine (235) 235
klinisk medicin (233) 233
humans (224) 224
neurologi (224) 224
aged (199) 199
female (196) 196
male (195) 195
neurosciences (169) 169
index medicus (148) 148
dementia (147) 147
middle aged (143) 143
cerebrospinal fluid (137) 137
aged, 80 and over (130) 130
clinical neurology (104) 104
psychiatry (102) 102
alzheimer disease - cerebrospinal fluid (96) 96
diagnosis (96) 96
biomarkers (87) 87
neurovetenskaper (83) 83
biomarkers - cerebrospinal fluid (78) 78
mild cognitive impairment (76) 76
amyloid beta-peptides - cerebrospinal fluid (69) 69
alzheimer disease - diagnosis (65) 65
geriatrics & gerontology (63) 63
psykiatri (60) 60
tau proteins - cerebrospinal fluid (57) 57
peptide fragments - cerebrospinal fluid (53) 53
cerebrospinal-fluid (51) 51
neuropsychological tests (50) 50
alzheimer disease (48) 48
alzheimers disease (46) 46
alzheimers-disease (46) 46
basic medicine (43) 43
medicinska och farmaceutiska grundvetenskaper (42) 42
beta-amyloid (41) 41
neurodegenerative diseases (41) 41
disease progression (38) 38
tau (37) 37
adult (34) 34
alzheimer’s disease (34) 34
biological markers (34) 34
memory (34) 34
research (34) 34
cognition (33) 33
brain (32) 32
pathology (32) 32
risk factors (32) 32
alzheimer disease - genetics (31) 31
geriatrics (31) 31
predictive value of tests (31) 31
cohort studies (30) 30
follow-up studies (29) 29
medicine (29) 29
analysis (28) 28
cognitive ability (28) 28
csf biomarkers (27) 27
longitudinal studies (27) 27
research article (26) 26
alzheimer disease - drug therapy (25) 25
case-control studies (25) 25
medical research (25) 25
plasma (25) 25
prospective studies (25) 25
protein (25) 25
vascular dementia (25) 25
alzheimer disease - psychology (24) 24
enzyme-linked immunosorbent assay (24) 24
medicine, experimental (24) 24
mental disorders (24) 24
activities of daily living (23) 23
alzheimer disease - blood (23) 23
cognition disorders - cerebrospinal fluid (23) 23
cognitive impairment (23) 23
genotype (23) 23
mass spectrometry (23) 23
prevalence (23) 23
80 and over (22) 22
alzheimer disease - physiopathology (22) 22
donepezil (22) 22
lewy bodies (22) 22
original research article (22) 22
sensitivity and specificity (22) 22
cholinesterase inhibitors (21) 21
dementia disorders (21) 21
internal medicine (21) 21
phosphorylation (21) 21
proteins (21) 21
tau protein (21) 21
tau proteins (21) 21
advertising executives (20) 20
studies (20) 20
apolipoproteins e - genetics (19) 19
csf (19) 19
mini-mental-state (19) 19
physiology (19) 19
psychiatric status rating scales (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, The, ISSN 1474-4422, 2009, Volume 8, Issue 7, pp. 613 - 618
Summary Background Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are common forms of dementia that substantially affect quality of... 
Neurology | DONEPEZIL | RIVASTIGMINE | DIAGNOSIS | DLB | ALZHEIMERS-DISEASE | CLINICAL NEUROLOGY | Outcome Assessment (Health Care) - methods | Humans | Cognition Disorders - metabolism | Male | Parkinson Disease - drug therapy | Psychomotor Performance - physiology | Patient Selection | Brain - metabolism | Reaction Time - drug effects | Aged, 80 and over | Cognition - physiology | Placebos | Female | Parkinson Disease - metabolism | Lewy Body Disease - drug therapy | Excitatory Amino Acid Antagonists - adverse effects | Memantine - administration & dosage | Cognition Disorders - physiopathology | Double-Blind Method | Placebo Effect | Brain - physiopathology | Excitatory Amino Acid Antagonists - administration & dosage | Treatment Outcome | Psychomotor Performance - drug effects | Reaction Time - physiology | Cognition - drug effects | Cognition Disorders - drug therapy | Parkinson Disease - physiopathology | Brain - drug effects | Lewy Body Disease - metabolism | Neuropsychological Tests | Aged | Glutamic Acid - metabolism | Lewy Body Disease - physiopathology | Memantine - adverse effects | Clinical trials | Medical colleges | Methyl aspartate | Care and treatment | Parkinson's disease | Nervous system agents | Dementia | Index Medicus | Clinical Medicine | Other Clinical Medicine | Neurologi | Medical and Health Sciences | Medicin och hälsovetenskap | Annan klinisk medicin | Klinisk medicin
Journal Article
Lancet Neurology, ISSN 1474-4422, 2009, Volume 8, Issue 7, pp. 619 - 627
Journal Article
Lancet Neurology, ISSN 1474-4422, 2006, Volume 5, Issue 3, pp. 228 - 234
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 01/2012, Volume 29, Issue 1, pp. 125 - 132
Neurodegenerative dementia, most frequently represented by Alzheimers disease (AD) and dementia with Lewy bodies (DLB), is often accompanied by altered... 
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, p. e30525
Chemokine (C-C motif) receptor 2 (CCR2)-signaling can mediate accumulation of microglia at sites affected by neuroinflammation. CCR2 and its main ligand CCL2... 
MICROGLIA | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | LIPOPOLYSACCHARIDE | CSF BIOMARKERS | MODEL | CEREBROSPINAL-FLUID | PROGRESSION | IMPAIRMENT | Cognition Disorders - cerebrospinal fluid | Alzheimer Disease - complications | Demography | Follow-Up Studies | Cognition Disorders - blood | Humans | Linear Models | Male | Cognitive Dysfunction - blood | Biomarkers - blood | Cognitive Dysfunction - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Chemokine CCL2 - blood | Disease Progression | Chemokine CCL2 - cerebrospinal fluid | Cognition Disorders - complications | Female | Aged | Biomarkers - cerebrospinal fluid | Alzheimer Disease - blood | Cohort Studies | Advertising executives | Development and progression | Alzheimer's disease | CC chemokine receptors | Memory | Cognitive ability | Cerebrospinal fluid | Eotaxin | CCR2 protein | Older people | Rodents | Dementia disorders | Aging | Population | Carbon-carbon composites | Task forces | Medical imaging | Cytokines | Neurodegenerative diseases | Inflammation | Metabolism | Patients | Microglia | Pathology | Signaling | Hypotheses | Brain research | Hospitals | Tau protein | Biomarkers | β-Amyloid | Alzheimers disease | Chemokines | Monocyte chemoattractant protein 1 | Dementia | Rheumatology and Autoimmunity | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | Reumatologi och inflammation | Klinisk medicin
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, p. e45451
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, p. e29868
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2012, Volume 11, Issue 7, pp. 597 - 604
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e53250
Journal Article
JAMA, ISSN 0098-7484, 07/2009, Volume 302, Issue 4, pp. 385 - 393
Journal Article